NM_013352.4:c.*4569T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_013352.4(DSE):​c.*4569T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.819 in 152,152 control chromosomes in the GnomAD database, including 51,849 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.82 ( 51840 hom., cov: 31)
Exomes 𝑓: 0.82 ( 9 hom. )

Consequence

DSE
NM_013352.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.22

Publications

8 publications found
Variant links:
Genes affected
DSE (HGNC:21144): (dermatan sulfate epimerase) The protein encoded by this gene is a tumor-rejection antigen. It is localized to the endoplasmic reticulum and functions to convert D-glucuronic acid to L-iduronic acid during the biosynthesis of dermatan sulfate. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. Mutations in this gene cause inmusculocontractural Ehlers-Danlos syndrome. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 9, and a paralogous gene exists on chromosome 18. [provided by RefSeq, Apr 2016]
DSE Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, musculocontractural type 2
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • Ehlers-Danlos syndrome, musculocontractural type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.942 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DSENM_013352.4 linkc.*4569T>C 3_prime_UTR_variant Exon 6 of 6 ENST00000644252.3 NP_037484.1 Q9UL01

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DSEENST00000644252.3 linkc.*4569T>C 3_prime_UTR_variant Exon 6 of 6 NM_013352.4 ENSP00000494147.2 Q9UL01
DSEENST00000452085.7 linkc.*4569T>C 3_prime_UTR_variant Exon 6 of 6 1 ENSP00000404049.2 Q9UL01
ENSG00000285446ENST00000644499.1 linkc.766+10721T>C intron_variant Intron 3 of 3 ENSP00000495266.1 A0A2R8Y6J1

Frequencies

GnomAD3 genomes
AF:
0.818
AC:
124411
AN:
152006
Hom.:
51786
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.950
Gnomad AMI
AF:
0.607
Gnomad AMR
AF:
0.836
Gnomad ASJ
AF:
0.824
Gnomad EAS
AF:
0.459
Gnomad SAS
AF:
0.673
Gnomad FIN
AF:
0.789
Gnomad MID
AF:
0.835
Gnomad NFE
AF:
0.780
Gnomad OTH
AF:
0.787
GnomAD4 exome
AF:
0.821
AC:
23
AN:
28
Hom.:
9
Cov.:
0
AF XY:
0.714
AC XY:
10
AN XY:
14
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.846
AC:
22
AN:
26
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
1
AN:
2
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.565
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.819
AC:
124524
AN:
152124
Hom.:
51840
Cov.:
31
AF XY:
0.816
AC XY:
60646
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.950
AC:
39448
AN:
41532
American (AMR)
AF:
0.836
AC:
12764
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.824
AC:
2861
AN:
3470
East Asian (EAS)
AF:
0.459
AC:
2374
AN:
5174
South Asian (SAS)
AF:
0.675
AC:
3248
AN:
4810
European-Finnish (FIN)
AF:
0.789
AC:
8353
AN:
10582
Middle Eastern (MID)
AF:
0.827
AC:
243
AN:
294
European-Non Finnish (NFE)
AF:
0.780
AC:
53029
AN:
67970
Other (OTH)
AF:
0.783
AC:
1652
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1088
2176
3263
4351
5439
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
866
1732
2598
3464
4330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.796
Hom.:
94372
Bravo
AF:
0.827
Asia WGS
AF:
0.623
AC:
2168
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.43
DANN
Benign
0.53
PhyloP100
-1.2

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs483981; hg19: chr6-116763077; API